In tumors with low levels of GSDME, activated caspase-3 elicits apoptosis, while if the tumor expresses high levels of GSDME, caspase-3 switches its downstream pathway from apoptosis to pyroptosis or apoptosis and pyroptosis [175,200]. Here, CASP3 is linked to neoplasm.